Find Hot

Enterprise hot news

Category: Kossel

  • SOLACI SOCIME 2025 | Unlock the Latin American Medical Market and Jointly Build a Global Health Future!

    SOLACI SOCIME 2025 | Unlock the Latin American Medical Market and Jointly Build a Global Health Future!

    The 2025 Annual Congress of the Latin American Society of Interventional Cardiology (SOLACI SOCIME 2025) was grandly held in Mexico from August 6 to 8. As the most influential cardiovascular intervention event in Latin America, SOLACI brought together experts and scholars in the field of cardiovascular intervention from various countries in Latin America and around the world. They jointly discussed and shared the latest research results and clinical experience, making it an important platform for showcasing cutting-edge technologies in global cardiovascular interventional diagnosis and treatment.

    Octoparms® Vena Cava Filter Tanghulu® Balloon MiStent® Coronary Drug-Eluting Stent

    Kossel’s Exhibited Products

    Octoparms® Vena Cava Filters

    In the core exhibition area of this congress, Kossel demonstrated innovative products and professional solutions in the fields of peripheral intervention, coronary intervention, and cardiac electrophysiology. Particularly, its core products that attracted much attention, such as the Octoparms® Vena Cava Filter, Tanghulu® Balloon, and MiStent® Coronary Drug-Eluting Stent, drew the attention of experts and business partners from countries including Mexico, Costa Rica, Panama, Brazil, Peru, and Colombia, who came to observe and communicate.

    Octoparms® Vena Cava Filter Tanghulu® Balloon MiStent® Coronary Drug-Eluting Stent

    We carefully listened to the suggestions and expectations of visitors regarding Kossel’s products, which provided directions for further improving product performance and developing customized services to meet the specific clinical needs in the Latin American region.

    Octoparms® Vena Cava Filter

    Tanghulu® Balloon

    MiStent® Coronary Drug-Eluting

    Through this congress, Kossel further gained insights into the regional national policies, clinical needs, market scale, and other information, and promoted the initiation of local registration. This laid a solid foundation for better serving overseas patients in the Latin American region in the future.

    Going forward, Kossel will continue to deepen its presence in the industry, integrate technologies and experiences from top experts around the world, and conduct innovative R&D. With higher-quality products and services, Kossel will empower clinical practice, benefit a large number of patients, and contribute the strength of a Chinese medical device brand to improving the cardiovascular health level in this region!

  • Reference Document | Expert Consensus on Ultrasound Interventional Therapy for Hemodialysis Vascular Access in China (2024 Edition)

    Abstract

    This consensus aims to provide clinical physicians with standardized guidance for ultrasound-guided PTA procedures, offer a reference for healthcare administrators in conducting quality control, and promote the wide application and popularization of ultrasound technology in arteriovenous dialysis access.

    Preoperative ultrasound assessment

    Sequence for ultrasound assessment of autologous AVF
    In the direction of blood flow along the internal fistula, successively evaluate the conditions of the inflow tract artery, the anastomosis site, the fistula vein all the way to the point where it joins the brachiocephalic vein to enter the subclavian vein or where the great saphenous vein joins the axillary vein.

    AVG ultrasonic assessment sequence
    In the direction of blood flow along the internal fistula, successively evaluate the conditions of the inflow tract artery, the arterial anastomosis, the entire segment of the graft, the venous anastomosis, the autologous outflow tract vein up to the point where it joins the brachiocephalic vein to enter the subclavian vein, or where the great saphenous vein joins the axillary vein throughout the entire vascular pathway.

    Evaluation content
    Blood flow volume, resistance index (RI), vascular morphology and structure (including vessel diameter, intima-media thickness, calcification status, vascular course and depth), stenosis location (including vessel diameter, length and peak systolic velocity ratio (PSVR), thrombus condition (including location, nature and amount of thrombus)

    Ultrasound manifestations and assessment indicators of vascular stenosis
    1.Blood flow: Under the condition of stable systemic hemodynamics, the natural blood flow of the autologous arteriovenous fistula (AVF) is less than 500 ml/min, and the natural blood flow of the arteriovenous graft (AVG) is less than 600 ml/min.
    2.Vascular inner diameter: For veins, the inner diameter of local blood vessels ≤ 1.7 mm or the inner diameter of long segments of blood vessels ≤ 2.0 mm, with a length ≥ 20 mm; for arteries, the inner diameter ≤ 2.0 mm; for veins, if the inner diameter is between 1.8 and 2.0 mm or for arteries, if the inner diameter is between 2.0 and 2.5 mm, a comprehensive judgment needs to be made based on the patient’s clinical symptoms, abnormal signs, and the effectiveness of hemodialysis.
    3.RI:RI>0.5;
    4.PSVR:PSVR>4。

    Indications and periods for PTA intervention

    Indications for intervention
    If the ultrasound assessment reveals that there is one or more areas of stenosis, occlusion or thrombosis in the autologous AVF or AVG, and the patient presents with any of the following one or more symptoms, it is recommended to consider performing PTA intervention.
    1.Physical examination findings: The tremor of the internal fistula has significantly weakened or disappeared, while the pulsation has become more pronounced; abnormal results were observed in the arm elevation test and the pulsation enhancement test.
    2.Abnormal blood flow: The pump-controlled blood flow during dialysis remained consistently below 200 ml/min.
    3.Significant increase in venous pressure: Venous pressure ≥ 200 mmHg, or dynamic venous pressure during dialysis continuously ≥ 160 mmHg
    4.Dialysis recirculation rate: Recirculation rate ≥ 15%
    5.Decrease in dialysis adequacy: The index of attack adequacy (Kt/V) has decreased without a clear cause by more than 0.2
    6.Extended bleeding time: After the dialysis treatment, the time required for stopping bleeding at the puncture site significantly increased (more than 20 minutes), and the influence of coagulation function and anticoagulants was excluded.
    7.Increased difficulty in puncture: The puncture operation becomes more challenging due to poor venous filling.

    Intervention timing
    For those meeting the PTA criteria, they should be managed through the specific time surgery. Under the condition that the patient’s vital signs are stable and there are no surgical contraindications, the PTA surgery should be completed within one dialysis period.

    PTA surgical procedure

    Anesthesia method
    It is recommended to use ultrasound-guided brachial plexus nerve block anesthesia.

    Access selection
    The fistula vein approach and the distal arterial approach are the most commonly used approaches for performing PTA surgery on AVF.
    The artificial vascular approach and the autologous vein approach are the most commonly used approaches for performing PTA surgery via the AVG.

    Surgical procedure
    a. Ultrasound-guided puncture
    b. Heparinization is carried out based on the patient’s condition.
    c. Utilizing the ultrasound probe from multiple angles to understand the details of the lesion, display the shape of the lesion opening and the channel, and assist in the passage of the guide wire.
    d. Balloon Dilatation
    ☑Non-compliant high-pressure balloons are the preferred choice for PTA surgery of arteriovenous dialysis access; for stubbornly narrow lesions, ultra-high-pressure balloons or cutting balloons can be selected. Special balloons can be chosen based on the access route to facilitate insertion.
    ☑The diameter of the balloon should be 1 to 2 mm larger than the inner diameter of the adjacent normal blood vessel; if the difference in inner diameters between the stenotic segment and the adjacent normal vessel is large or there is a thrombotic lesion, it can be gradually expanded; the length of the balloon should not exceed the length of the lesion by too much to avoid damaging the normal vessel.
    ☑For multi-site lesions, the dilation sequence in the reverse blood flow direction can be adopted, with priority given to relieving the stenosis of the outflow tract. The duration of a single balloon dilation is generally controlled within 30 to 60 seconds.
    e.Postoperative hemostasis: compression hemostasis, purse-string suture, 8-shaped suture
    f.Postoperative puncture care planning was carried out, and postoperative precautions were informed.

    Standard for successful surgery

    Technical success criteria
    Self-vascularized arteriovenous fistula (AVF) blood flow ≥ 500 ml/min, AVG blood flow ≥ 600 ml/min; RI < 0.5; Residual stenosis rate at the lesion site < 30%, PSVR < 2

    Clinical success criteria
    The internal fistula tremor can be palpated and has recovered or significantly intensified; the dialysis was successful for two consecutive times after the operation, and the pump-controlled blood flow was ≥ 200 ml/min

    Complication identification

    🔘 Hematoma at the puncture site
    🔘 Vascular spasm
    🔘 Vascular dissection
    🔘 Vascular rupture
    🔘 Pseudoaneurysm
    🔘 Acute thrombosis formation
    🔘 Balloon rupture
    🔘 Fracture of the guidewire and catheter

    Thrombosis treatment of dialysis access

    Drug thrombolysis, mechanical thrombectomy through aspiration, and open surgical thrombectomy methods

    The application of ultrasound technology in other surgical procedures

    ☑ If the retraction after balloon dilation exceeds 50%, if the stenosis recurs twice consecutively within a short period of time, if there is a severe dissection or pseudoaneurysm during the operation, etc., stent implantation can be considered, and covered stents are recommended. The clinical data of stent implantation under ultrasound guidance are not yet sufficient, so when choosing ultrasound as the guiding method, caution should be exercised.
    ☑ Ultrasound-guided balloon-assisted maturation technique (BAM) is the first-line treatment for immature arteriovenous fistulas. When choosing the balloon size, caution should be exercised. In case of necessity, gradual dilation can be performed, and contingency plans for vascular rupture should be formulated.
    ☑ PTA should be the initial treatment for cephalic arch stenosis (CAS). This procedure can be performed under the guidance of DSA or ultrasound. However, stent implantation for CAS is not recommended to be done under ultrasound guidance.
    ☑For high-flow arteriovenous fistulas that cause dialysis access-related extremity ischemia syndrome or high-output heart failure, it is recommended to perform ultrasound-guided arteriovenous dialysis access flow-limiting surgery to reduce the blood flow in the fistula.

  • Meet Kossel Medtech atSOLACI SOCIME 2025

    Meet Kossel Medtech atSOLACI SOCIME 2025 congress
    Welcome to our
    Booth Number: PA#13

    Meet Kossel Medtech atSOLACI SOCIME 2025

  • Seledora® Coronary Scoring Balloon Catheter– Product Overview

    “Precise lesion preparation” and “vascular functional restoration” are the main themes in current coronary interventional therapy.

    Compared with common balloon angioplasty, which compresses plaques in a disordered manner, scoring balloons offer a more targeted solution. On the one hand, the scoring elements focus pressure on the lesion, enabling controlled plaque modification and reducing the risk of irregular dissections that could restrict blood flow. On the other hand, for moderate to severe, especially circumferential calcified lesions that are often hard to cross with other devices, scoring balloons can embed their elements into the plaque and dilate it at low pressure. This approach helps to gradually open the lesion, creating favorable conditions for further lumen preparation and maintenance—— achieving true precise lesion preparation.

    Seledora® Coronary Scoring Balloon Catheter

    Seledora® Coronary Scoring Balloon Catheter

    The Seledora® Coronary Scoring Balloon Catheter features a deliverability profile of 0.0165″, equivalent to a conventional pre-dilatation balloon. It is equipped with three triangular nylon scoring ridges, each 0.42 mm in height, evenly distributed at 120° intervals along the balloon’s proximal and distal ends. This design ensures excellent lumen gain while maintaining good crossability.

    Balloon Catheter

    Ex Vivo Simulation Results
    The Seledora® scoring balloon demonstrated uniform and consistent scoring morphology aligned with the direction of blood flow, indicating effective and controlled plaque modification.

    Seledora® scoring balloon

    Seledora® scoring balloon2

    Seledora® scoring balloon3

    Clinical Benefits

    The immediate lumen gain in the test group showed no statistically significant difference from the control group, confirming the non-inferiority of the Seledora device. Safety and secondary efficacy outcomes were also comparable between the two groups.

    Specifications Chart

    PTCA BALLOON DILATATION CATHETER

    By enabling low-pressure, focused dilatation and directional, controlled plaque scoring, the Seledora® Coronary Scoring Balloon Catheter facilitates effective lumen gain and precise lesion preparation. This paves the way for optimized lumen modification and maintenance, enhances the drug release performance of DES (drug-eluting stents) and DCB (drug-coated balloons), reduces restenosis, ensures long-term treatment efficacy, and ultimately benefits the patient.

  • Seledora Coronary Scoring Balloon Catheter

    Seledora Coronary Scoring Balloon Catheter

    Seledora® Coronary Scoring Balloon Catheter is Now Available
    Low-pressure focused dilation, safe and effective, flexible and efficient, helping to fully pre-dilate the coronary artery

  • Celebratory News丨Selethru® PTCA balloon dilatation catheter has obtained the CE MDR certification

    Celebratory News丨Selethru® PTCA balloon dilatation catheter has obtained the CE MDR certification

    Recently, Kossel’s independently developed Selethru® PTCA balloon dilatation catheter has successfully passed the EU Medical Device Regulation (MDR) certification, marking that the product has met the highest international standards in terms of safety, effectiveness and clinical performance.

    Selethru®-PTCA-balloon-dilatation-catheter

    Europe is a globally important medical device market. The acquisition of MDR certification has provided strong support for Kossel to continue its in-depth expansion into Europe and its affiliated markets. In the future, the company will continue to advance the “Local Base, Global Reach” overseas strategy, strengthen cooperation with global medical institutions and experts, and enable more patients to benefit from Chinese medical devices!

  • Deepening Latin American Ties — Kossel Medtech Strikes a New Chord in the Land of Samba

    Deepening Latin American Ties — Kossel Medtech Strikes a New Chord in the Land of Samba

    Hospitalar 2025 | São Paulo, Brazil | May 20–23

    Hospitalar, one of South America’s most influential healthcare exhibitions, concluded successfully in São Paulo. Leveraging Brazil’s strategic position in Latin America, the event has become a key platform for regional medical integration and international collaboration.


    At this major event, Kossel Medtech showcased a portfolio of flagship products and localized solutions—highlighting our latest innovations in vascular intervention to a global audience.

    Brazil, home to Latin America’s largest healthcare market, is a core part of Kossel’s strategic expansion. Our Falspeed® Peripheral PTA Balloon Catheter and Falexpand® High-Pressure Peripheral Balloon Catheter have already been certified by ANVISA, laying a strong foundation for local growth.

    During the exhibition, Kossel Medtech welcomed partners and distributors from Brazil, Argentina, Mexico, Colombia, Peru, Chile, South Korea, and Ecuador. Our high-performance products and globally trusted solutions drew widespread interest, further solidifying our presence and reputation across Latin America.

    Looking ahead, Kossel Medtech will continue to advance innovation in vascular intervention, accelerate our global market strategy, and deliver high-quality, application-driven solutions to healthcare professionals worldwide.

    Innovation Without Borders. Reach Without Limits.

    #Kossel Medtech #Hospitalar2025 #LatinAmericaHealthcare #MedTechInnovation #PeripheralIntervention #GlobalExpansion #ANVISA #MedicalDevices #BrazilMedTech #VascularSolutions #HealthcareExhibition #Falspeed #Falexpand #LocalBaseGlobalReach #LifeSciences

  • Cathios® CARDIAC ABLATION CATHETER

    Cathios® CARDIAC ABLATION CATHETER

    Cathios® CARDIAC ABLATION CATHETER

    A. Easy Control
    1:1 twisting force feedback makes tip placement convenient and quick

    B. Excellent Tip and Special design Curve Part
    16X2 strands wire braid curve part and brilliant tip help catheter stay close to cardiac structure

    C. Adjust Precisely
    It is easy to locate the target points of heart with accurate bending of head part of catheter

    D. Comfortable Handle
    1. Ergonomic design help catheter push through the vessel conveniently
    2. Surface is skidproof and comfortable to hold

    E. Compatibility
    The extension cable is designed with various interfaces, suitable for different devices

  • Falspeed® PTA Balloon Dilatation Catheter

    PTA balloon catheter is mainly used for limb blood vessels, extended to the arteries, such as renal artery, coronary artery, and  vein, such as the expansion of the vena cava stenosis, and treatment of artificial blood vessels, transplant vascular stenosis or occlusion.

    1. A wide range of diameters and lengths are available, covering different clinical demands

    2. The 3 wing or 6 wing folding techniques make the balloon’s profile small, raising passing capability for challenging stenosis

    3. The soft and tapered tip helps the balloon get through lesions easily

    4. The hydrophilic coating reduces friction during pushing process